Amanda M. Farr, MPH

Articles by Amanda M. Farr, MPH

Real-World Impact of Comparative Effectiveness Research Findings on Clinical Practice

ByTeresa B. Gibson, PhD,Emily D. Ehrlich, MPH,Jennifer Graff, PharmD,Robert Dubois, MD,Amanda M. Farr, MPH,Michael E. Chernew, PhD,A. Mark Fendrick, MD

June 30th 2014

The authors found no consistent pattern in the concordance between CER evidence and subsequent utilization patterns.

Comparison Between Guideline-Preferred and Nonpreferred First-Line HIV Antiretroviral Therapy

ByStephen S. Johnston, MA,Timothy Juday, PhD,Amanda M. Farr, MPH,Bong-Chul Chu, PhD,Tony Hebden, PhD

June 19th 2014

Initiation of guideline-preferred first-line antiretroviral therapy (ART) was associated with better ART adherence and persistence and similar total healthcare expenditures among Medicaid-insured HIV patients.

Amanda M. Farr, MPH

Articles by Amanda M. Farr, MPH

Real-World Impact of Comparative Effectiveness Research Findings on Clinical Practice

Comparison Between Guideline-Preferred and Nonpreferred First-Line HIV Antiretroviral Therapy

Latest Updated Articles

Trending on AJMC

Special Report: The Oncology Care Model, 10 Years Later

Patients on GLP-1s Increasingly Carry Diagnoses for New Indications

Targeting Oxidative Stress Could Fill a Gap in the Vitiligo Treatment Toolbox

How Hospital Specialty Pharmacies Are Closing the Pharmacy Desert Gap

Contributor: Turning Headwinds Into Momentum—How Value-Based Care Can Help Payers Manage Costs and Regain Stability